Alan Scott Enterprises Ltd

Alan Scott Ente. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Alan Scott Enterprises Ltd

₹ 304 -2.00%
06 Nov - close price
thealanscott.com BSE: 539115
About

Incorporated in 1994, Alan Scott Industries manufacture health and hygiene products for use in hospitals and homes

Key Points

Product Profile:
a) 5 petals AIR purifier+[1]
This uses 8 different technologies instead of 5 certified technologies to provide protection from aerosol spread of 99.9% of Virus, Bacteria, fungus and Yeasts
b) 5 Petals O2 Concentrator[2]
It's a supplement of oxygen with a capacity
of 8-25 LPM and a High Purity Oxygen 90-95%

Clientele:[3]
Larsen & Tubro, Som Capital, Rubix,
Thought Bridge HR, Verstech, Sunicon, Sanjivani Parentrals3

Website BSE
  • Market Cap ₹ 166 Cr.
  • Current Price ₹ 304
  • High / Low ₹ 345 / 92.0
  • Stock P/E
  • Book Value ₹ 3.28
  • Dividend Yield 0.00 %
  • ROCE -14.2 %
  • ROE -142 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 92.8 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -127% over last 3 years.
  • Earnings include an other income of Rs.2.25 Cr.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Media, Entertainment & Publication Entertainment Film Production, Distribution & Exhibition

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
0.89 1.26 1.84 1.22 1.39 2.34 3.89 4.27 6.14 6.79 7.81 8.14 9.24
1.08 1.60 1.76 1.26 1.39 2.36 3.82 4.02 5.77 6.13 7.62 7.42 8.21
Operating Profit -0.19 -0.34 0.08 -0.04 0.00 -0.02 0.07 0.25 0.37 0.66 0.19 0.72 1.03
OPM % -21.35% -26.98% 4.35% -3.28% 0.00% -0.85% 1.80% 5.85% 6.03% 9.72% 2.43% 8.85% 11.15%
0.00 0.05 0.06 -0.05 0.04 0.05 0.08 0.06 0.00 0.00 1.86 0.39 0.00
Interest 0.08 0.08 0.20 0.21 0.31 0.31 0.43 0.56 0.36 0.35 0.53 0.95 0.51
Depreciation 0.17 0.18 0.35 0.37 0.40 0.47 0.67 0.87 0.86 0.85 0.97 1.11 0.89
Profit before tax -0.44 -0.55 -0.41 -0.67 -0.67 -0.75 -0.95 -1.12 -0.85 -0.54 0.55 -0.95 -0.37
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.44 -0.55 -0.41 -0.67 -0.66 -0.75 -0.95 -1.12 -0.86 -0.55 0.55 -0.95 -0.38
EPS in Rs -0.80 -0.94 -0.67 -1.07 -1.06 -1.19 -1.56 -1.91 -1.48 -1.07 1.15 -1.63 -0.42
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0.02 1.24 5.17 11.42 28.69 31.98
0.11 1.90 5.60 11.47 26.75 29.38
Operating Profit -0.09 -0.66 -0.43 -0.05 1.94 2.60
OPM % -450.00% -53.23% -8.32% -0.44% 6.76% 8.13%
0.09 0.67 0.06 0.35 2.25 2.25
Interest 0.00 0.02 0.61 1.38 2.20 2.34
Depreciation 0.00 0.05 1.08 2.41 3.80 3.82
Profit before tax 0.00 -0.06 -2.06 -3.49 -1.81 -1.31
Tax % 0.00% 0.00% 0.00% 0.00%
0.00 -0.07 -2.06 -3.50 -1.82 -1.33
EPS in Rs 0.00 -0.11 -3.50 -6.48 -3.37 -1.97
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 185%
TTM: 92%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 68%
Stock Price CAGR
10 Years: 41%
5 Years: 96%
3 Years: 132%
1 Year: 184%
Return on Equity
10 Years: %
5 Years: %
3 Years: -127%
Last Year: -142%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 1.19 1.83 1.83 3.62 3.63
Reserves 0.35 1.25 -0.64 -0.26 -1.86
0.05 0.17 3.00 8.62 7.38
0.00 2.32 6.20 15.87 18.10
Total Liabilities 1.59 5.57 10.39 27.85 27.25
0.00 2.60 6.01 15.03 15.82
CWIP 0.00 0.00 0.00 0.00 0.00
Investments 0.30 0.21 0.21 0.89 1.36
1.29 2.76 4.17 11.93 10.07
Total Assets 1.59 5.57 10.39 27.85 27.25

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.18 -1.58 -2.78 -3.11 -1.68
-0.21 -0.95 0.31 -3.05 0.10
1.29 1.73 2.15 8.53 -0.15
Net Cash Flow 1.26 -0.80 -0.33 2.37 -1.74

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 0.00 2.94 0.71 13.10 7.89
Inventory Days 124.03 227.11 211.75 88.66
Days Payable 88.59 107.76 126.84 15.87
Cash Conversion Cycle 0.00 38.38 120.06 98.01 80.68
Working Capital Days -730.00 73.59 -46.60 -70.63 26.33
ROCE % -27.63% -35.79% -26.39% -14.21%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
46.45% 46.45% 48.56% 61.67% 60.77% 60.77% 61.79% 63.54% 63.56% 63.77% 66.60% 66.80%
0.74% 0.74% 0.74% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.25% 0.25%
52.82% 52.81% 50.70% 37.97% 38.85% 38.86% 37.84% 36.09% 36.07% 35.86% 33.15% 32.96%
No. of Shareholders 6,7596,8276,8476,9246,7526,8076,7696,9156,9456,9937,2477,070

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Aug 2025
    Transcript
    Notes
    PPT
  • Aug 2025
    Transcript
    Notes
    PPT